- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
November 24th, 2005
An Australian academic has been chosen as editor-in-chief of the first scholarly magazine devoted to the ethics of nanotechnology.
John Weckert, a Wagga Wagga-based expert on information technology and philosophy at Charles Sturt University, has been putting the finishing touches to an editorial board for the new journal, Nanoethics: Ethics for technologies that converge at the nanoscale.
(Ed.'s note: Well, almost the "first scholarly magazine devoted to the ethics of nanotechnology." Guess they missed seeing the notice about Nanotechnology Perceptions. Not that it hurts to have more groups involved in preparing for nanotechnology, in fact it is a good thing, but there are several other groups, notably the ones we interviewed for this month's report: Nanoethics Group, Science, Technology and Society Program, Center for Responsible Nanotechnology, NanoScience & Technology Studies: Societal and Ethical Implications Project, and of course the Foresight Nanotech Institute.
BTW - "the grey goo problem" is not a problem - see Gray Goo is a Small Issue.)
|Related News Press|
PETA science consortium to present at Society for Risk Analysis meeting December 10th, 2014
Scientists disagree on responsible research April 8th, 2014
Preparing for Nano
Durnham University's DEEPEN project comes to a close September 26th, 2012
Technical Seminar at ANFoS 2012 August 22nd, 2012
Nanotechnology shows we can innovate without economic growth April 12th, 2012
Thailand to host NanoThailand 2012 December 18th, 2011
Physicists solve quantum tunneling mystery: ANU media release: An international team of scientists studying ultrafast physics have solved a mystery of quantum mechanics, and found that quantum tunneling is an instantaneous process May 27th, 2015
Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies: If results are confirmed in humans, tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections; new NIH grant will fund future study May 27th, 2015